APA

Angenendt L., Kerkhoff A., Wiebe S., Mikesch J., Rudat A., Wötzel F., Wenning C., Schliemann C., Kessler T., Schäfers M., Wardelmann E., Stelljes M. & Berdel W. E. (20150724). Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease. : Annals of hematology.

Chicago

Angenendt Linus, Kerkhoff Andrea, Wiebe Stefanie, Mikesch Jan-Henrik, Rudat Annika, Wötzel Fabian, Wenning Christian, Schliemann Christoph, Kessler Torsten, Schäfers Michael, Wardelmann Eva, Stelljes Matthias and Berdel Wolfgang E. 20150724. Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease. : Annals of hematology.

Harvard

Angenendt L., Kerkhoff A., Wiebe S., Mikesch J., Rudat A., Wötzel F., Wenning C., Schliemann C., Kessler T., Schäfers M., Wardelmann E., Stelljes M. and Berdel W. E. (20150724). Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease. : Annals of hematology.

MLA

Angenendt Linus, Kerkhoff Andrea, Wiebe Stefanie, Mikesch Jan-Henrik, Rudat Annika, Wötzel Fabian, Wenning Christian, Schliemann Christoph, Kessler Torsten, Schäfers Michael, Wardelmann Eva, Stelljes Matthias and Berdel Wolfgang E. Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease. : Annals of hematology. 20150724.